| Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 | Dec'16 | Sep'16 | Jun'16 | Mar'16 | Dec'15 | Sep'15 | Jun'15 | Mar'15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows Used In Operating Activities | |||||||||||||||||||
Net loss | |||||||||||||||||||
-199,293 | -25,738 | -31,900 | -48,649 | -17,540 | -12,555 | -10,031 | -14,065 | -13,790 | -13,129 | -19,699 | -23,149 | -25,193 | -15,775 | -11,999 | -173,811 | -8,267 | -17,088 | 356,488 | -11,319 |
Adjustments to reconcile net loss to net cash and restricted cash used in operating activities: | |||||||||||||||||||
Change in fair value of contingent consideration and indemnification asset | |||||||||||||||||||
-3,697 | -500 | 100 | 100 | -2,700 | 100 | -1,604 | 100 | 100 | 100 | 200 | 0 | - | - | - | - | - | - | - | - |
Loss from equity method investees | |||||||||||||||||||
-3,278 | -3,859 | -1,928 | -400 | -1,949 | -1,381 | -1,306 | -100 | -309 | -369 | -555 | -522 | -379 | -448 | -14 | 0 | 0 | 0 | -16,846 | -11,319 |
Depreciation and amortization expenses | |||||||||||||||||||
15,947 | 15,408 | 15,292 | 14,266 | 14,633 | 10,352 | 10,034 | 9,496 | 11,132 | 7,717 | 6,904 | 6,615 | 6,496 | 3,745 | 3,612 | 3,371 | 3,126 | 3,056 | 984 | 0 |
Goodwill impairment | |||||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 160,600 | 0 | 0 | 0 | 0 |
Stock-based compensation expense | |||||||||||||||||||
573 | 5,758 | 4,750 | 4,537 | 5,049 | 4,047 | 4,718 | 3,795 | 4,265 | 5,708 | 5,360 | 5,104 | 4,760 | 4,799 | 4,710 | 4,335 | 4,194 | 4,382 | 6,154 | 0 |
Deferred tax provision (benefit) | |||||||||||||||||||
-22,936 | -970 | 1,274 | -492 | 10 | 205 | -129 | -42 | -4,603 | -2,388 | -685 | 405 | -9,141 | -254 | -372 | -988 | -5,709 | -104 | 29,273 | 0 |
Amortization of contract cost assets | |||||||||||||||||||
1,591 | 1,359 | 1,523 | 1,250 | 803 | 734 | 596 | 570 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - |
Amortization of deferred financing costs | |||||||||||||||||||
2,416 | 2,354 | 2,321 | 2,279 | 1,767 | 229 | 230 | 229 | 229 | 229 | 227 | 229 | 0 | 0 | 0 | 0 | - | - | - | - |
Accretion of bond premium (discount) | |||||||||||||||||||
- | - | - | - | - | - | - | - | - | - | 48 | 57 | - | - | 0 | 0 | - | - | - | - |
Other current operating cash inflows (outflows), net | |||||||||||||||||||
239 | 552 | -100 | -427 | -559 | 56 | -151 | 206 | -402 | 203 | -132 | -159 | -473 | -167 | -166 | -110 | -79 | -69 | -24 | 0 |
Changes in assets and liabilities, net of acquisitions: | |||||||||||||||||||
Accounts receivable, net and contract assets | |||||||||||||||||||
254 | 3,311 | 4,905 | -14,796 | 13,502 | -10,285 | 4,151 | 17,135 | 6,183 | -2,827 | 3,899 | 4,003 | 9,439 | -8,351 | 5,121 | 4,835 | -8,093 | 6,502 | -10,165 | 0 |
Prepaid expenses and other current and noncurrent assets | |||||||||||||||||||
-2,282 | -7,391 | 4,708 | 4,174 | -647 | 2,640 | 143 | 12,610 | -7,854 | 3,713 | 783 | 629 | 9,856 | -317 | 1,085 | -656 | 688 | 341 | 1,007 | 0 |
Contract cost assets | |||||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | 0 | - | - | - | - | - | - | - | - |
Contract cost assets | |||||||||||||||||||
8,075 | 6,872 | 3,545 | 4,565 | 6,611 | 3,806 | 407 | 355 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - |
Accounts payable | |||||||||||||||||||
-1,487 | -5,018 | 1,229 | -204 | 1,147 | 6,793 | -2,676 | 2,334 | -5,028 | 3,550 | 2,819 | 4,222 | -2,679 | -717 | -79 | -2,896 | 1,691 | 2,186 | -1,113 | 0 |
Accrued liabilities | |||||||||||||||||||
-1,191 | -16,494 | -7,772 | 3,605 | -1,766 | 7,806 | 931 | 5,209 | 8,294 | -7,454 | 3,106 | -6,727 | 9,064 | 3,641 | 1,110 | 1,414 | 2,596 | -7,333 | 949 | 0 |
Accrued compensation and employee benefits | |||||||||||||||||||
7,666 | 186 | 10,985 | -9,591 | -7,512 | 5,787 | 6,724 | -19,570 | 4,404 | 8,923 | 4,794 | -21,424 | 7,316 | 4,296 | 7,368 | -12,302 | 5,080 | 8,951 | -2,629 | 0 |
Deferred revenue | |||||||||||||||||||
-2,873 | -4,222 | 4,603 | 1,736 | -2,647 | -7,439 | -2,602 | 10,869 | -1,287 | -1,884 | 2,138 | 4,581 | -1,682 | -1,131 | 519 | 3,494 | -16,564 | 6,375 | -7,809 | 0 |
Reserve for claims and performance-based arrangements | |||||||||||||||||||
18,077 | 10,021 | 3,033 | 2,424 | -1,374 | 872 | 2,767 | 6,699 | - | - | - | - | - | - | - | - | - | - | - | - |
Right-of-use operating assets | |||||||||||||||||||
-3,596 | -943 | 12,857 | 12,493 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating lease liabilities | |||||||||||||||||||
-823 | 506 | 14,808 | 13,233 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Claims reserves | |||||||||||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 | 0 | - | - | - | - | - | - | - | - |
Other long-term liabilities | |||||||||||||||||||
-521 | -48 | -168 | -4,618 | 2,120 | 226 | 1,018 | -154 | -63 | 2,776 | -3,768 | -727 | -270 | 26 | 43 | 48 | 58 | 0 | 0 | 0 |
Net cash and restricted cash used in operating activities | |||||||||||||||||||
13,187 | -16,590 | -13,533 | -25,709 | -24,968 | 22,321 | 6,701 | -24,705 | 6,035 | 3,819 | -3,047 | -34,765 | -21,505 | 7,913 | -1,114 | -20,804 | -6,311 | -6,349 | -5,808 | 0 |
Cash Flows Used In Investing Activities | |||||||||||||||||||
Cash paid for asset acquisitions or business combinations | |||||||||||||||||||
0 | 2,575 | 0 | 6,000 | 118,689 | -124 | 0 | 11,676 | 0 | 453 | 3,241 | 0 | 68,560 | -500 | 3,000 | 11,500 | 0 | 0 | 0 | 0 |
Customer advance for regulatory capital requirements | |||||||||||||||||||
0 | 1,000 | 40,000 | 5,400 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - | - |
Principal repayment of implementation funding loan and regulatory and capital requirements | |||||||||||||||||||
0 | 2,570 | 2,830 | 0 | 6,000 | 6,000 | 4,000 | 4,000 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - |
Amount received from escrow in asset acquisition | |||||||||||||||||||
0 | 0 | 0 | 0 | 0 | 0 | 0 | 500 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - |
Investments in and advances to equity method investees | |||||||||||||||||||
70,367 | 221 | 16,555 | 337 | 2,553 | 2,807 | 0 | 4,000 | 1,128 | 0 | 0 | 0 | - | - | - | - | - | - | - | - |
Purchases of investments | |||||||||||||||||||
2,225 | 1,778 | 3,343 | 3,779 | 10,010 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - | - |
Maturities and sales of investments | |||||||||||||||||||
- | - | - | - | - | - | - | - | 0 | 24,000 | 9,610 | 10,600 | 5,280 | 1,999 | 2,100 | 0 | - | - | - | - |
Investments in and purchases of property and equipment | |||||||||||||||||||
9,157 | 8,638 | 8,277 | 9,462 | 10,433 | 8,874 | 10,690 | 9,553 | 6,499 | 8,919 | 6,452 | 5,978 | 4,410 | 3,856 | 3,907 | 3,353 | 2,608 | 2,892 | 1,015 | 0 |
Purchases of restricted investments | |||||||||||||||||||
- | 2 | -7 | 500 | - | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - | - |
Purchase and maturities of restricted investments | |||||||||||||||||||
495 | 0 | 0 | 0 | 106 | 0 | 1 | -8,044 | 605 | 0 | 3,200 | 0 | 6,144 | 0 | 4 | -1,198 | - | 0 | 0 | 0 |
Net cash and restricted cash used in investing activities | |||||||||||||||||||
-79,174 | -11,644 | -65,338 | -25,478 | -135,442 | -5,557 | -6,691 | -12,685 | -28,232 | 14,628 | -3,283 | 4,622 | -73,834 | -4,357 | -4,811 | -13,655 | -54,819 | -4,915 | 16,050 | 0 |
Cash Flows (Used In) from Financing Activities | |||||||||||||||||||
Changes in working capital balances related to claims processing on behalf of partners | |||||||||||||||||||
-81,487 | 96,725 | -12,006 | -107,500 | 113,497 | -10,086 | 15,010 | -22,268 | 21,448 | -3,651 | -13,496 | -8,501 | - | - | - | - | - | - | - | - |
Amount received from escrow in asset acquisition | |||||||||||||||||||
0 | 0 | 0 | 500 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred financing costs related to 2025 Notes | |||||||||||||||||||
- | -1 | 0 | 608 | - | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - | - |
Proceeds from stock option exercises | |||||||||||||||||||
95 | 49 | 825 | 123 | 1,341 | 5,896 | 3,231 | 1,461 | 280 | 242 | 3,018 | 542 | 15 | 1,130 | 89 | 25 | 60 | 54 | 38 | 0 |
Taxes withheld and paid for vesting of restricted stock units | |||||||||||||||||||
201 | 3 | 225 | 2,180 | 57 | 80 | 299 | 800 | 93 | 4 | 508 | 667 | 0 | 47 | 318 | 0 | - | - | - | - |
Net cash and restricted cash (used in) from financing activities | |||||||||||||||||||
-11,246 | 96,772 | -11,406 | -109,665 | 281,959 | -4,270 | 17,942 | -21,607 | 21,635 | 163,534 | -10,986 | -8,626 | 149,306 | 1,083 | -229 | 25 | 4,984 | 54 | 209,125 | 0 |
Effect of exchange rate on cash and cash equivalents and restricted cash | |||||||||||||||||||
11 | 48 | -10 | -19 | -71 | 28 | 11 | -4 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - |
Net increase (decrease) in cash and cash equivalents | |||||||||||||||||||
-77,222 | 68,586 | -90,287 | -160,871 | 121,478 | 12,522 | 17,963 | -59,001 | -562 | 181,981 | -17,316 | -38,769 | 53,967 | 4,639 | -6,154 | -34,434 | -56,146 | -11,210 | 219,367 | 0 |
Supplemental Disclosure of Non-cash Investing and Financing Activities | |||||||||||||||||||
Non-cash contribution of common stock to Evolent Health LLC prior to the Offering Reorganization | |||||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 13,791 | 8,019 |
Accrued property and equipment purchases | |||||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | 276 | 8 | 90 | - | 53 | 0 | 0 |
Class A common stock issued in connection with business combinations | |||||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 10,534 | - | 0 | 0 | 0 |
Increase to goodwill from measurement period adjustments related to business combinations | |||||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | - | - | - | - |
Decrease in accrued financing costs related to 2021 Notes | |||||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | - | - | - | - |
Decrease in non-controlling interests as a result of the Exchange | |||||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | 28,220 | 0 | 0 | - | - | - | - |
Decrease in non-controlling interests as a result of Class B Exchanges | |||||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | 28,220 | 0 | 0 | - | - | - | - |